Twitter Facebook LinkedIn YouTube

Orion Nutraceuticals (CSE:ORI) New Listing

Video Platform Video Management Video Solutions Video Player

The Vancouver-based company, in conjunction with its network of sports medicine experts, is creating a line of sports medicine, CBD based, products.

Additional Information:

Company: Orion Nutraceuticals
Website: http:// www.orionnutra.ca
Stock Symbol: CSE: ORI
Date Published: Oct 18, 2018
Transcript: Available

Video Transcript:

I’m Samantha Deutscher for Investmentpitch Media
Orion Nutraceuticals (CSE:ORI) is one of the latest new listing on the Canadian Securities Exchange, trading under the symbol “ORI”.

The Vancouver-based company, in conjunction with its network of sports medicine experts, is creating a line of sports medicine, CBD based, products.

The company’s target market is athletes, athletic therapists, sports medicine retailers, homeopathic and pharmaceutical companies, manufacturers, distributors, wholesalers, consumers and retailers.

In conjunction with its professional sports strategic alliances, the company is poised to advance research and development in the plant science sector, deliver science-based products and services to the mainstream, with proprietary brands and products.

Through its Quebec subsidiary, Medic Oasis, the company aims to become an ACMPR Licensed Producer in Quebec and is currently in Stage 5 of its Health Canada application process.

Build out is expected to begin in Q1 2019, with completion of the 30,000 square foot facility expected by Q3 2019.

The company has a joint venture with Medellin-based FMC Global, Colombia's first fully licensed producer and exporter for non-psychoactive cannabis for medical and research purposes.

FCM is also in the final stages of receiving its high-THC licenses, which is anticipated in the 4th quarter of 2018.

FMC Global will soon break ground on FCM Tolima, a planned 450-hectare cultivation and production site which will have production capabilities of over 1,000 tons of cannabis oil when at full capacity.

Carlos Velasquez, CEO of FCM Global, stated: "FCM congratulates Orion on achieving another significant milestone. We are proud to partner with Orion as they execute their winning formula of high-quality products plus large-scale production capacity."

Jonathan Fiteni, CEO, stated: “We are extremely excited to launch Orion Nutraceuticals as Canada celebrates the legalization of recreational cannabis. We aim to set a new standard in cannabis life science by producing and developing innovative sports medicine products with key, strategic partners in the industry. Through our partners in Colombia, FCM Global, and our domestic cannabis production facility, we intend to become the leaders in cannabis derived CBD therapies.”

The shares are currently trading at $0.75.

For more information, please visit the company’s website at www.orionnutra.ca, contact Robin Linden, Director Investor Relations, 604-313-2768 or email investors@orionnutra.ca..

I’m Samantha Deutscher for Investmentpitch Media